Nick Maskell leads the Bristol Academic Respiratory Unit. He also runs a tertiary pleural disease service and chairs the regional mesothelioma multi-disciplinary team.

He was the Chief Investigator for AERATOR, one of the only non-therapeutic urgent public health badged COVID-19 studies in the UK.

One of his major research interests is the evaluation of novel biomarkers for investigating and managing pleural disease.

View all research projects

A new approach to diagnosing thoracic endometriosis

Endometriosis is where cells similar to those in the lining of the womb grow in…

Theme Respiratory disease

Workstream Personalised care in pleural disease

Can pleural fluid cell differentiation accurately diagnose the cause of fluid around the lung?

Pleural effusion – a build-up of fluid around the lungs – can be caused by…

Theme Respiratory disease

Workstream Airways diseases

Does inflammation play a role in pleural empyema?

Pleural empyema is a serious condition that develops when pus builds up in the…

Theme Respiratory disease

Workstream Personalised care in pleural disease

How do inflammation and asbestos exposure interact in developing pleural mesothelioma?

Pleural mesothelioma (PM) is a cancer of the lining of the lung caused by…

Theme Respiratory disease

Workstream Omics for prediction and prognosis

Testing a new drainage system for patients with fluid build-up around their lungs

A common treatment for patients with fluid build-up around the lungs is to have…

Theme Respiratory disease

Workstream Personalised care in pleural disease

Improving diagnosis and outcome prediction in pleural mesothelioma

Pleural mesothelioma is a cancer of the lining of the lungs. This is known as…

Theme Respiratory disease

Workstream Personalised care in pleural disease

Using circulating tumour DNA to diagnose pleural mesothelioma

As a tumour or cancer grows, its cells die and are replaced by new ones.

Theme Respiratory disease

Workstream Personalised care in pleural disease